Ionis Pharmaceuticals Inc to discuss Olezarsen Top Line Phase 3 results. Transcript - Thomson StreetEvents

Ionis Pharmaceuticals Inc to discuss Olezarsen Top Line Phase 3 results. Transcript

Ionis Pharmaceuticals Inc to discuss Olezarsen Top Line Phase 3 results. Transcript - Thomson StreetEvents
Ionis Pharmaceuticals Inc to discuss Olezarsen Top Line Phase 3 results. Transcript
Published Sep 26, 2023
16 pages (10181 words) — Published Sep 26, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of IONS.OQ conference call or presentation 26-Sep-23 3:00pm GMT

  
Brief Excerpt:

...Operator Good morning, and welcome to Ionis' Conference Call to discuss the mechanism and biology behind olezarsen and the top line results from the Phase III Balance study. As a reminder, this call is being recorded. At this time, I would like to turn the call over to Wade Walke, Senior Vice President of Investor Relations, to lead off the call. Wade, you may begin. D. Wade Walke ...

  
Report Type:

Transcript

Source:
Company:
Ionis Pharmaceuticals Inc
Ticker
IONS.OQ
Time
3:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Ionis Pharmaceuticals Inc at Guggenheim Securities Inflammation & Immunology Conference Summary – 2023-11-07 – US$ 54.00 – Edited Brief of IONS.OQ presentation 7-Nov-23 4:10pm GMT

Ionis Pharmaceuticals Inc at Guggenheim Securities Inflammation & Immunology Conference Transcript – 2023-11-07 – US$ 54.00 – Edited Transcript of IONS.OQ presentation 7-Nov-23 4:10pm GMT

Ionis Pharmaceuticals Inc Q3 2023 Earnings Call Summary – 2023-11-02 – US$ 54.00 – Edited Brief of IONS.OQ earnings conference call or presentation 2-Nov-23 3:30pm GMT

Ionis Pharmaceuticals Inc Q3 2023 Earnings Call Transcript – 2023-11-02 – US$ 54.00 – Edited Transcript of IONS.OQ earnings conference call or presentation 2-Nov-23 3:30pm GMT

Ionis Pharmaceuticals Inc to discuss Olezarsen Top Line Phase 3 results. Summary – 2023-09-26 – US$ 54.00 – Edited Brief of IONS.OQ conference call or presentation 26-Sep-23 3:00pm GMT

Ionis Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Summary – 2023-09-12 – US$ 54.00 – Edited Brief of IONS.OQ presentation 12-Sep-23 4:15pm GMT

Ionis Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript – 2023-09-12 – US$ 54.00 – Edited Transcript of IONS.OQ presentation 12-Sep-23 4:15pm GMT

Ionis Pharmaceuticals Inc at Citi BioPharma Conference Transcript – 2023-09-07 – US$ 54.00 – Edited Transcript of IONS.OQ presentation 7-Sep-23 5:50pm GMT

Ionis Pharmaceuticals Inc at Wells Fargo Healthcare Conference Transcript – 2023-09-06 – US$ 54.00 – Edited Transcript of IONS.OQ presentation 6-Sep-23 4:45pm GMT

Ionis Pharmaceuticals Inc Q2 2023 Earnings Call Summary – 2023-08-09 – US$ 54.00 – Edited Brief of IONS.OQ earnings conference call or presentation 9-Aug-23 3:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ionis Pharmaceuticals Inc to discuss Olezarsen Top Line Phase 3 results. Transcript" Sep 26, 2023. Alacra Store. May 17, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Ionis-Pharmaceuticals-Inc-to-discuss-Olezarsen-Top-Line-Phase-3-results-T15757031>
  
APA:
Thomson StreetEvents. (2023). Ionis Pharmaceuticals Inc to discuss Olezarsen Top Line Phase 3 results. Transcript Sep 26, 2023. New York, NY: Alacra Store. Retrieved May 17, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Ionis-Pharmaceuticals-Inc-to-discuss-Olezarsen-Top-Line-Phase-3-results-T15757031>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.